PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 82 filers reported holding PLIANT THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,736,774 | -4.3% | 100,160 | 0.0% | 1.12% | -0.9% |
| Q2 2023 | $1,814,899 | -31.9% | 100,160 | 0.0% | 1.13% | -33.7% |
| Q1 2023 | $2,664,256 | +25.1% | 100,160 | -9.1% | 1.70% | +12.0% |
| Q4 2022 | $2,129,393 | -7.5% | 110,160 | 0.0% | 1.52% | -20.2% |
| Q3 2022 | $2,301,000 | +139.2% | 110,160 | -8.3% | 1.90% | +126.3% |
| Q2 2022 | $962,000 | +14.3% | 120,160 | 0.0% | 0.84% | +25.0% |
| Q1 2022 | $842,000 | -48.1% | 120,160 | 0.0% | 0.67% | -44.7% |
| Q4 2021 | $1,622,000 | -20.0% | 120,160 | 0.0% | 1.22% | -27.8% |
| Q3 2021 | $2,028,000 | -42.0% | 120,160 | 0.0% | 1.68% | -41.6% |
| Q2 2021 | $3,499,000 | – | 120,160 | – | 2.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 339,160 | $5,881,034 | 100.00% |
| CHI Advisors LLC | 3,014,199 | $52,266,211 | 20.72% |
| TRV GP IV, LLC | 2,132,867 | $36,983,914 | 13.93% |
| GREAT POINT PARTNERS LLC | 1,755,184 | $30,434,891 | 5.54% |
| First Light Asset Management, LLC | 2,933,260 | $50,862,728 | 4.83% |
| Deep Track Capital, LP | 5,500,000 | $95,370,000 | 3.68% |
| Casdin Capital, LLC | 1,577,108 | $27,347,053 | 3.03% |
| Fernwood Investment Management, LLC | 379,702 | $6,584,033 | 2.37% |
| Redmile Group, LLC | 2,678,099 | $46,438,237 | 2.21% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 250,409 | $4,342,092 | 1.32% |